Form 4: Accuray Inc. Director Anne Bryce Le Grand Acquires Restricted Stock Units

Director Anne Bryce Le Grand of Accuray Inc. was granted 56,603 restricted stock units on November 29, 2024, which will vest on November 21, 2025.

Summary

• Anne Bryce Le Grand, a director at Accuray Inc., received 56,603 restricted stock units (RSUs) on November 29, 2024.
• These RSUs represent a contingent right to receive one share of Accuray's common stock each.
• The RSUs will vest 100% on November 21, 2025.
• The transaction was reported on December 3, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of equity compensation for a director, which is generally viewed positively as it aligns interests with shareholders. There are no negative implications.

Positives

• The grant of restricted stock units to a director aligns their interests with the long-term performance of the company.
• The vesting period of approximately one year may encourage the director to remain engaged with the company.

Industry Context

This is a standard practice for compensating directors and aligning their interests with shareholders in publicly traded companies.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across various industries, including technology and healthcare, to incentivize performance and retention.
• Companies like Varian Medical Systems and Elekta, which are competitors of Accuray, also use equity-based compensation for their directors.
• The vesting period of approximately one year is also typical for such grants.

Stakeholder Impact

• The grant of RSUs to a director may be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

restricted stock units, RSU, director, insider trading, beneficial ownership, Accuray Inc., ARAY, equity compensation